| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A combined pharmacokinetic model for the hypoxia-targeted prodrug PR-104A in humans, dogs, rats and mice predicts species differences in clearance and toxicity
|
Patel, Kashyap
|
|
2010
|
67 |
5 |
p. 1145-1155
|
article
|
| 2 |
An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting
|
Kyritsis, Athanassios P.
|
|
2011
|
67 |
5 |
p. 971-983
|
article
|
| 3 |
A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer
|
Chouaid, Christos
|
|
2010
|
67 |
5 |
p. 1203-1208
|
article
|
| 4 |
Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs
|
Frömberg, Anja
|
|
2010
|
67 |
5 |
p. 1157-1166
|
article
|
| 5 |
Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells
|
Tapia-Pérez, Jorge Humberto
|
|
2010
|
67 |
5 |
p. 1193-1201
|
article
|
| 6 |
Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis
|
Medeiros, C. A. C. X.
|
|
2010
|
67 |
5 |
p. 1085-1100
|
article
|
| 7 |
Erratum to: Reductive metabolism of the dinitrobenzamide mustard anticancer prodrug PR-104 in mice
|
Gu, Yongchuan
|
|
2011
|
67 |
5 |
p. 1209
|
article
|
| 8 |
H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein
|
Wei, Ning
|
|
2010
|
67 |
5 |
p. 1017-1025
|
article
|
| 9 |
Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent
|
Green, Carol E.
|
|
2010
|
67 |
5 |
p. 995-1006
|
article
|
| 10 |
Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study
|
Konings, Inge R. H. M.
|
|
2010
|
67 |
5 |
p. 1055-1062
|
article
|
| 11 |
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma
|
Airoldi, Mario
|
|
2010
|
67 |
5 |
p. 1027-1034
|
article
|
| 12 |
In reply
|
Basso, Michele
|
|
2011
|
67 |
5 |
p. 1191-1192
|
article
|
| 13 |
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patients
|
Ng, Chee M.
|
|
2010
|
67 |
5 |
p. 985-994
|
article
|
| 14 |
Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors
|
Ueda, Yutaka
|
|
2010
|
67 |
5 |
p. 1101-1109
|
article
|
| 15 |
Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study
|
Waddell, T.
|
|
2010
|
67 |
5 |
p. 1111-1117
|
article
|
| 16 |
Phase I, pharmacokinetic, and biological studies of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, administered after meals with solid tumors
|
Murakami, Haruyasu
|
|
2010
|
67 |
5 |
p. 1119-1128
|
article
|
| 17 |
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity
|
Basso, Michele
|
|
2010
|
67 |
5 |
p. 1179-1187
|
article
|
| 18 |
Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates
|
Joerger, M.
|
|
2010
|
67 |
5 |
p. 1137-1144
|
article
|
| 19 |
Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells
|
Suzuki, Maiko
|
|
2010
|
67 |
5 |
p. 1129-1136
|
article
|
| 20 |
Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death
|
Kaminski, Bettina M.
|
|
2010
|
67 |
5 |
p. 1167-1178
|
article
|
| 21 |
Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals
|
Suddek, Ghada M.
|
|
2010
|
67 |
5 |
p. 1035-1044
|
article
|
| 22 |
Tanespimycin pharmacokinetics: a randomized dose-escalation crossover phase 1 study of two formulations
|
Burris, Howard A.
|
|
2010
|
67 |
5 |
p. 1045-1054
|
article
|
| 23 |
Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase
|
Guin, Sunny
|
|
2010
|
67 |
5 |
p. 1073-1083
|
article
|
| 24 |
The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
|
Park, Susanna B.
|
|
2011
|
67 |
5 |
p. 1189-1190
|
article
|
| 25 |
The efficacy and safety of gemcitabine plus paclitaxel combination first-line therapy for Japanese patients with metastatic breast cancer including triple-negative phenotype
|
Aogi, Kenjiro
|
|
2010
|
67 |
5 |
p. 1007-1015
|
article
|
| 26 |
Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects
|
Enomoto, Riyo
|
|
2010
|
67 |
5 |
p. 1063-1072
|
article
|
Journal description